$BWAY News

HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17

BrainsWay To Invest $1.5M Initially, With Potential For Additional $1.5M Via Milestone-Based Investments, For Minority Position In Hopemark In Form Of Preferred, Annually Compounding Security

Full Transcript: BrainsWay Q1 2026 Earnings Call

BrainsWay Affirms FY2026 Sales Guidance of $66.000M-$68.000M vs $66.350M Est

BrainsWay Q1 EPS $0.06 Beats $0.05 Estimate, Sales $15.531M Beat $14.539M Estimate

BrainsWay: Competitive Threats Are Mounting

BrainsWay: Strong Execution, But Valuation Limits Upside

BrainsWay Completes Additional $6M Milestone-Based Convertible Loan To Neurolief

BrainsWay Completes $1M Investment In Axis Management

HC Wainwright & Co. Maintains Buy on BrainsWay, Lowers Price Target to $15

BrainsWay Ltd. (BWAY) Q4 2025 Earnings Call Transcript

BrainsWay Reports Q4 Earnings: Revenue Beat, Guidance Below Estimates

BrainsWay Sees FY2026 Sales $51.000M-$52.000M vs $64.986M Est

BrainsWay Q4 EPS $0.04, Inline, Sales $14.545M Beat $14.011M Estimate

Uncovering Potential: BrainsWay's Earnings Preview

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1

BrainsWay New Clinical Data Shows SWIFT Deep TMS Cuts Depression Treatment To 6 Sessions

BrainsWay shares are trading lower. The company announced new minority-stake investment in BrainStim Health.

BrainsWay shares are trading lower. The company announced new minority-stake investment in BrainStim Health.

BrainsWay To Invest Up To $2.5M In BrainStim Health